Hydropothecary Closes $25.1 Million Bought Deal Private Placement of Convertible Debenture Units
TORONTO, ON--(Marketwired - July 18, 2017) - The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) is pleased to announce the closing of its previously announced bought deal private placement of convertible debenture units for aggregate gross proceeds of $25.1 million (the "Offering"), which includes the partial exercise of the over-allotment option by the underwriters.